Total Funding
24
49
Total FundingSeries B raised
Growth Score
-4 pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
106885
TTS Pharma is a UK-based biotechnology company developing technologies to support the pharmacogenetic stratification of patients.
Mark Tucker: Founder & CEO
About the Company
TTS Pharma was formed in late 2012 to acquire Transdermal Technology & Systems (TTS) Limited as part of a strategic investment and corporate restructuring to prepare it for growth and to enable the group to undertake activities in both Europe and Asia. TTS Limited is a wholly owned subsidiary of TTS Pharma and undertakes its operating
activities primarily in UK.
